SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Intermediate follow-up) — Frances Burney

PatientFrances Burney
Date of birth1967-06-13
IdentifiersMRN HR-EN013-SYN; SSN (made up) 000-13-9108
Document date2026-08-24
AuthorHarriet Pell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review of breast imaging and biopsy results. [S]

History of Present Illness

Mrs. Burney returns two weeks after presenting with a right breast lump and a year of heavy, dull breast ache. The diagnostic mammogram and ultrasound twelve days ago showed a 2.4 cm spiculated mass at 10 o'clock in the right breast, BI-RADS 5, with normal axillary nodes and dense breast tissue. The ultrasound-guided core biopsy ten days ago shows invasive ductal carcinoma, grade 2, strongly estrogen and progesterone receptor positive and HER2 negative. The ache is unchanged and does not wake her. She has no bone pain, cough, headaches, abdominal pain, or weight loss. She saw Dr. Marsh of breast surgery this morning. She is frightened of an operation and has asked that every step be explained beforehand and that she be warned before anything is done; with that, she feels able to go ahead. She has no family history of breast or ovarian cancer that she knows of, but her mother died when she was ten and little is known of her mother's family. [S]

ElementDetail
Interval changeImaging BI-RADS 5; core biopsy invasive ductal carcinoma, ER and PR positive, HER2 negative
SymptomsUnchanged dull ache; no symptoms of spread
CoordinationBreast surgery seen this morning
Family historyLimited: mother died when she was ten
ConcernsFear of surgery; wants each step explained and to be warned in advance

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo weight loss, fever, or night sweats
BreastPositiveRight breast lump with a dull ache; no nipple discharge or skin change
MusculoskeletalNegativeNo bone pain
RespiratoryNegativeNo cough or breathlessness
NeurologicalNegativeNo headaches
PsychiatricPositiveWorried and sleeping less since the diagnosis; PHQ-9 5, GAD-7 7

6 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-24Body height160cmS
2026-08-24Body weight61.6kgS
2026-08-24Body mass index (BMI) [Ratio]24.1kg/m2S
2026-08-24Systolic blood pressure132mm[Hg]S
2026-08-24Diastolic blood pressure82mm[Hg]S
2026-08-24Heart rate86/minS
2026-08-24Respiratory rate14/minS
2026-08-24Body temperature36.6CelS
2026-08-24Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-24Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-08-24Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S

Physical Exam

Vital signs recorded on 2026-08-24; see the Vital Signs section. [S]

SystemFinding
GeneralAnxious but composed
BreastsRight breast: 2.5 cm hard, irregular mass at 10 o'clock, mobile on the chest wall, with a small bruise from the biopsy; no skin dimpling or nipple change. Left breast normal
Lymph nodesNo axillary, supraclavicular, or infraclavicular nodes
AbdomenSoft; liver not enlarged

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the right breast, upper outer quadrant at 10 o'clock, presenting as a firm lump after about a year of breast ache; core biopsy: grade 2, estrogen and progesterone receptor positive, HER2 negative; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern diagnosis linked to the documented 1811 breast disease and mastectomy, whose cancer diagnosis is debatedactiveconfirmed C50.411S — Synthetic diagnosis confirmed by biopsy and surgical pathology in the modern episode; whether her historical disease was cancer remains a retrospective interpretation (R).
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 70 percent)activeconfirmed Z17.0S — Synthetic receptor result; no tissue from her lifetime was examined.
Firm lump in the upper outer quadrant of the right breast after about a year of heavy breast ache; clinically suspicious, imaging and biopsy bookedresolvedconfirmed N63.11S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the year of breast ache echoes her documented account (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ImagingDiagnostic mammography and ultrasound of the breast and axillaAt presentation with a palpable massUp to dateDone twelve days ago: 2.4 cm spiculated mass, BI-RADS 5; normal axillary nodes; dense breasts
LaboratoryCore biopsy with ER, PR, and HER2 testingAt diagnosisUp to dateInvasive ductal carcinoma, grade 2; ER 95 percent, PR 70 percent, HER2 1+ (negative), Ki-67 15 percent
ImagingBreast MRI for extent of diseaseOptional at diagnosis; considered for dense breasts or when surgical planning is uncertainOrderedBooked in four days
ImagingCT, bone scan, or PET for distant spreadOnly with symptoms or clinical stage IIINot indicatedClinical stage T2 N0 with no symptoms of spread
LaboratoryTumor markers (CEA, CA 15-3, CA 27.29)Not recommended for early breast cancerNot indicatedNot ordered
LaboratoryGermline genetic testingAt diagnosis, for breast cancer at 65 or youngerCompleted todayMultigene panel sample sent today; result expected in about three weeks, before surgery
SurveyDistress, depression, and anxiety screen (PHQ-9 and GAD-7)At diagnosis and at periodic intervalsCompleted todayPHQ-9 5 and GAD-7 7, mild; supported today and offered the cancer center's counseling service
ExaminationLymphedema baseline arm measurementsBefore axillary surgeryDueTo be measured at the pre-anesthesia visit before surgery
ReferralBreast surgeryAt diagnosisCompleted todaySeen this morning; recommendations in the consultation note
ReferralMedical oncologyAfter surgery, with the surgical pathologyDueTo review the pathology and recurrence score after surgery
Medication safetyPre-anesthesia evaluationBefore surgeryOrderedPre-anesthesia clinic visit to be booked once the date is set
Self-managementActivity and preparation for surgeryEvery visitCompleted todayWalking 30 minutes a day; never smoker; shoulder exercise leaflet given

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024 (2024); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)

Follow-up: Breast MRI in four days. Genetic result in about three weeks. Surgery date from the breast surgery team. Primary care review about three weeks after surgery. Next scheduled visit 2026-10-19: review three weeks after right mastectomy; start of endocrine therapy and survivorship care. [S]